Human Growth Hormone Market Share & Trend Analysis is Expected To Reach USD 15.66 Billion By 2032, at a CAGR of 11.4% | Polaris Market Research, Inc.

The Human Growth Hormone Market, in terms of revenue, was evaluated to be worth USD 5.95 billion in 2023 and is foreseen to reach USD 15.66 billion by 2032, growing at a CAGR of 11.4% from 2024 to 2032, according to a new report by Polaris Market Research. The main driver of market growth is the increasing frequency of growth hormone deficiency (GHD).

Human growth hormone (HGH), typically known as growth hormone, is a hormone built by the pituitary gland at the bottom of the brain in the development stage of life. HGH is a naturally occurring hormone that helps humans grow. It aids in the development of bones, the maintenance and repair of brain and organ tissue, and the stimulation of cell division and renewal.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/human-growth-hormone-market/request-for-sample

Humans can also have growth hormone insufficiency due to a number of hereditary disorders, such as Turner syndrome, Prader-Willi syndrome, and idiopathic short stature (ISS), which results in delayed puberty and shorter-than-average height.

Furthermore, several conditions, including genetic disorders, severe brain traumas, and pituitary gland absence at birth, propel the human growth hormone market. Also, an increasing number of product releases in the upcoming years will result from rising research and development expenses by companies due to the market's potential growth.

𝐓𝐡𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

• AnkeBio Co., Ltd
• Ascendis Pharma
• Eli Lilly and Company
• Ferring Pharmaceuticals
• Genentech, Inc (Roche)
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz International GmbH

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3655/2

𝐇𝐮𝐦𝐚𝐧 𝐆𝐫𝐨𝐰𝐭𝐡 𝐇𝐨𝐫𝐦𝐨𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:

• The long-acting segment is projected to expand at the highest CAGR during the forecast period, owing to the safety profile & effectiveness of long-acting human growth hormones.

• In 2023, the growth hormone deficiency segment accounted for the largest market share, owing to the high prevalence of the disease and the rising number of new products for its treatment.

• In 2023, the hospital pharmacies segment accounted for the largest market share, owing to the increasing number of patient visits to hospitals.

• North America accounted for the largest revenue share in the human growth hormone market in 2023, owing to the rising cases of Turner syndrome and growth hormone deficiencies.

The market players include AnkeBio Co., Ltd, Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech, and more.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

In 2023, market revenue was highest in North America. One of the main factors propelling the market expansion in this region is the high frequency of Turner syndrome and human growth hormone insufficiency. Also, throughout the projection period, Asia Pacific is expected to see the greatest CAGR. In the upcoming years, it is anticipated that the human growth hormone market will develop more rapidly due to the increased prevalence of uncommon genetic illnesses and rising awareness of human growth hormone insufficiency.

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/human-growth-hormone-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

𝐁𝐲 𝐓𝐲𝐩𝐞:

• Long-acting
• Short-acting & Intermediate-acting

𝐁𝐲 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧:

• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Intramuscular

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

𝐆𝐚𝐬 𝐓𝐮𝐫𝐛𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/gas-turbine-market-powering-efficiency-reliability-energy-mohit-harne-mhpqf

𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐒𝐚𝐟𝐞𝐭𝐲 𝐂𝐚𝐛𝐢𝐧𝐞𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/biological-safety-cabinet-market-safeguarding-ummaf

𝐀𝐢𝐫𝐜𝐫𝐚𝐟𝐭 𝐀𝐜𝐭𝐮𝐚𝐭𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/aircraft-actuator-market-driving-precision-control-aviation-2v7wf

𝐆𝐮𝐧𝐬𝐡𝐨𝐭 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/gunshot-detection-system-market-enhancing-public-twcrf

𝐌𝐢𝐥𝐢𝐭𝐚𝐫𝐲 𝐕𝐞𝐭𝐫𝐨𝐧𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/military-vetronics-market-advancing-vehicle-electronics-zelnf

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.